Difficulty: Medium
Average Score: 64%
Practice
Tick the drug belonging to aromatase inhibitors:
Correct answer
B
Rationale
In pharmacological lifespan treatment, understanding the mechanism of action and classification of drugs is crucial. Aromatase inhibitors are used in the treatment of hormone receptor-positive breast cancer, particularly in postmenopausal women. Among the options provided, the correct answer is B) Anastrozole.
Anastrozole is an aromatase inhibitor that works by suppressing the enzyme aromatase, which is responsible for estrogen production. By inhibiting estrogen synthesis, Anastrozole helps in reducing estrogen levels in the body, which is beneficial in hormone-dependent breast cancer treatment.
Now, let's analyze why the other options are incorrect:
A) Octreotide: Octreotide is a somatostatin analog used to treat conditions like acromegaly and some types of tumors, but it is not an aromatase inhibitor.
C) Flutamide: Flutamide is an antiandrogen used in the treatment of prostate cancer, but it does not belong to the class of aromatase inhibitors.
D) Tamoxifen: Tamoxifen is a selective estrogen receptor modulator (SERM) that blocks estrogen's effects on breast tissue. It is not an aromatase inhibitor like Anastrozole.
Educationally, understanding the classification of drugs based on their mechanism of action is essential for effective pharmacological treatment. This knowledge helps healthcare professionals in making informed decisions about drug selection, dosage, and monitoring for optimal patient outcomes. By grasping the distinctions between different drug classes, practitioners can provide personalized and evidence-based care to patients.
Anastrozole is an aromatase inhibitor that works by suppressing the enzyme aromatase, which is responsible for estrogen production. By inhibiting estrogen synthesis, Anastrozole helps in reducing estrogen levels in the body, which is beneficial in hormone-dependent breast cancer treatment.
Now, let's analyze why the other options are incorrect:
A) Octreotide: Octreotide is a somatostatin analog used to treat conditions like acromegaly and some types of tumors, but it is not an aromatase inhibitor.
C) Flutamide: Flutamide is an antiandrogen used in the treatment of prostate cancer, but it does not belong to the class of aromatase inhibitors.
D) Tamoxifen: Tamoxifen is a selective estrogen receptor modulator (SERM) that blocks estrogen's effects on breast tissue. It is not an aromatase inhibitor like Anastrozole.
Educationally, understanding the classification of drugs based on their mechanism of action is essential for effective pharmacological treatment. This knowledge helps healthcare professionals in making informed decisions about drug selection, dosage, and monitoring for optimal patient outcomes. By grasping the distinctions between different drug classes, practitioners can provide personalized and evidence-based care to patients.